================================================================================
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): May 18, 2006
--------------------------------------------------------------
SPIRE CORPORATION
--------------------------------------------------------------------------------
(Exact Name of Registrant as Specified in Charter)
Massachusetts 0-12742 04-2457335
--------------------------------------------------------------------------------
(State or Other Jurisdiction (Commission (IRS Employer
of Incorporation) File Number) Identification No.)
One Patriots Park, Bedford, Massachusetts 01730-2396
----------------------------------------- ----------
(Address of Principal Executive Offices) (Zip Code)
(781) 275-6000
--------------------------------------------------------------------------------
(Registrant's telephone number, including area code)
Check the appropriate box below if the Form 8-K filing is intended to
simultaneously satisfy the filing obligation of the registrant under any of the
following provisions (see General Instruction A.2. below):
[_] Written communications pursuant to Rule 425 under the Securities Act (17
CFR 230.425)
[_] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR
240.14a-12)
[_] Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))
[_] Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))
================================================================================
ITEM 5.02. DEPARTURE OF DIRECTORS OR PRINCIPAL OFFICERS; ELECTION OF DIRECTORS;
APPOINTMENT OF PRINCIPAL OFFICERS.
On May 18, 2006, the Board of Directors of Spire Corporation (the
"Company") approved the appointment of Christian Dufresne as Chief Financial
Officer, effective May 18, 2006. On May 24, 2006, the Company issued a press
release announcing Dr. Dufresne's appointment, a copy of which is attached
hereto as Exhibit 99.1.
Dr. Dufresne, age 43, most recently served as Vice President -
Corporate Planning of the Company, and has served in this role since 2005. Prior
to that Dr. Dufresne held the title of Chief Financial Officer for Spire
Biomedical, where he was engaged in financing activities with that business unit
and was involved in its licensing and contracting activities. He has been with
the Company for six years. Prior to working with Spire, he was a Consultant for
Stratford Associates, a market research firm that perform economic market
modeling for Fortune 500 companies. Dr. Dufresne holds a Ph.D. in Economics with
concentrations in industrial organization and finance from Clark University.
ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.
(d) EXHIBITS
Exhibit No. Description
----------- -----------
99.1 Press Release of the Company dated May 24, 2006.
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934,
the registrant has duly caused this report to be signed on its behalf by the
undersigned hereunto duly authorized.
SPIRE CORPORATION
Date: May 24, 2006 By: /s/ Roger G. Little
-------------------------------------
Roger G. Little
President and Chief Executive Officer
EXHIBIT INDEX
Exhibit No. Description
----------- -----------
99.1 Press Release of the Company dated May 24, 2006.